<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - FDA Issues Guidelines on COVID-19 Trials
Image Overlay - FDA Issues Guidelines on COVID-19 Trials

FDA Issues Guidelines on COVID-19 Trials

FDA Issues Guidelines on COVID-19 Trials

The FDA released a new set of guidelines for potential coronavirus vaccines, noting that they must be at least 50% effective in a placebo-controlled trial.“While the FDA is committed to help expedite this work, we will not cut corners in our decision making and we are making clear in our guidance what are the data we need that should be submitted to meet our regulatory standards for approval,” said FDA Commissioner Stephen Hahn, MD. The race to bring a treatment and a vaccine from trials to market is underway, and Yourway has been there since the beginning of the pandemic, in support of all clinical trial needs.

Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Clinical Trial Supply New England

April 14-15, 2026
Boston, MA

GCSG 2026 US Conference

April 27-29, 2026
San Diego, CA

Media

Articles

White-Glove by Design: The Yourway Standard in Clinical Logistics

Open chat
Come chat with us!
Hello! How can I help you?